Senti Biosciences is a Bay Area biotech company focused on outsmarting complex diseases with more intelligent medicines.

Senti Biosciences leverages expertise in cell engineering and biological programming to build the future of gene and cell based therapies.

• Industry

  • Biotechnology

• Milestones

  • Lux investment: 2016

• Latest Tweets

  • #News: We’re excited to announce that we will be presenting two posters at the Society for Immunotherapy of Cancer… https://t.co/GJtL92744p@SentiBio - 4h
  • Attending @ChardanCM’s 6th Annual Genetic Medicines Conference? Join Senti’s CEO and Co-founder, Tim Lu, MD, PhD to… https://t.co/JdKpJDsdrF@SentiBio - 12:03 PM Oct 4th
  • Senti’s Deb Knobelman, PhD, Tim Lu, MD, PhD, and Kanya Rajangam, MD, PhD will be hosting a fireside chat at… https://t.co/pCcLYOSI0j@SentiBio - 04:10 PM Oct 3rd